Movement Pattern Biofeedback Training After Total Knee Arthroplasty (MOVE)

April 22, 2025 updated by: University of Colorado, Denver
This research study explores the effects of movement pattern training using real-time biofeedback insoles after total knee arthroplasty. The purpose of this research study is to determine if the addition of a novel movement pattern training program (MOVE) to contemporary progressive rehabilitation leads to improved movement quality and physical function compared to contemporary progressive rehabilitation (CONTROL) alone.

Study Overview

Detailed Description

Currently in the United States, more than 700,000 total knee arthroplasty (TKA) surgeries are performed annually, with projections of 3.5 million performed annually by 2030. The increasing incidence of TKA comes with an immediate need for establishing optimal rehabilitation guidelines to remediate common post-TKA physical impairments and improve functional outcomes. Over the past decade, a primary focus of the investigators' TKA rehabilitation research has been on progressive strengthening, which improves muscle strength and physical function, and is now the contemporary approach to TKA rehabilitation. However, a major issue remaining for patients rehabilitating from unilateral TKA is the persistence of atypical movement patterns. These atypical movement patterns, observed during walking and other functional tasks, are characterized by disuse of the surgical limb, resulting in smaller knee extension moments on the surgical limb compared to the non-surgical limb. As a result, atypical movement patterns following unilateral TKA are associated with persistent quadriceps weakness and poor physical function.

The investigators will conduct a randomized controlled trial of 150 participants undergoing unilateral TKA to determine if the addition of a novel movement pattern training program (MOVE) to contemporary, progressive rehabilitation improves movement pattern quality more than contemporary progressive rehabilitation alone (CONTROL). The secondary goal is to determine if movement pattern training improves long-term physical function. Testing will occur pre-operatively and after TKA at 10 weeks (end of intervention), 6 months (primary endpoint), and 24 months.

Study Type

Interventional

Enrollment (Actual)

138

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 50-85 years old
  2. primary, unilateral knee arthroplasty for end-stage osteoarthritis

Exclusion Criteria:

  1. Moderate to severe contralateral knee OA (>4/10 on verbal pain rating (VPR) or KL grade >3)
  2. Current smoker
  3. Drug abuse
  4. Comorbid conditions that substantially limit physical function or would interfere with the participant's ability to successfully complete rehabilitation (e.g. neurologic, vascular, cardiac problems, or ongoing medical treatments)
  5. Discharge to location other than home after surgery
  6. Unstable orthopedic conditions that limit function
  7. Uncontrolled diabetes (hemoglobin A1c level >8.0)
  8. Body mass index >40 kg/m2
  9. Surgical complication necessitating an altered course of rehabilitation
  10. Previous contralateral TKA
  11. Unable to safely walk 30m without an assistive device

Exclusion criteria for MRI

  1. Ferromagnetic metal implants or pacemakers
  2. Other contraindications to MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: MOVE
Movement pattern training in addition to contemporary progressive rehabilitation
The MOVE program emphasizes movement pattern retraining in conjunction with contemporary rehabilitation. More specifically, the MOVE program promotes symmetry in functional knee motion and loading without postural compensation. Intervention uses pressure-sensing shoe insoles to deliver real-time visual biofeedback during activity performance.
Active Comparator: CONTROL
Contemporary progressive rehabilitation
The contemporary progressive rehabilitation program consists of progressive resistive exercise to key lower extremity muscle groups, knee range of motion exercise, weight-bearing exercise, as well as education on symptom management strategies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Peak Knee Extension Moment (PKEM) during walking at fixed speed
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Peak Knee Extension Moment (PKEM) during walking at a fixed speed of 1.0 m/s
Baseline, 10 weeks, 6 months, and 2 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PKEM during activities
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
PKEM during walking at self-selected gait speed, rising and lowering from a chair, and stepping up and down a step
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Six-minute Walk (6MW) Test
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Developed and used extensively to measure endurance, measures the distance walked in six minutes.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Stair Climbing Test (SCT)
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Measures a higher level of function that minimizes the possibility of a ceiling effect
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in 30-Second Sit-to-Stand Test (30-STS)
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Assesses lower body strength and the fatigue effect caused by the number of sit-to-stand repetitions.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Accelerometer-based Physical Activity
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Assesses daily physical activity levels and number of steps.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Quadriceps Strength
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Assesses the maximal voluntary isometric contraction strength of the quadriceps muscle
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Assesses self-reported physical function. Scale assess pain, stiffness, and physical function in patients with hip and / or knee osteoarthritis. Total score range is 0-96. Total score is computed by summing three subscales: pain (range 0-20), stiffness (range 0-8), and functional limitations (range 0-68), then dividing by total points possible. Higher scores indicate worse pain, stiffness, and functional limitations.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Veterans RAND 12 item health survey (VR-12)
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
A generic instrument to measure health related quality of life. The VR-12 has two subscales, the Physical Component Score (PCS) and the Mental Component Score (MCS). The PCS and MCS summary scores are standardized using a t-score transformation and normed to a U.S. population (based on a 1990 norm) of a score of 50 and a standard deviation of 10.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in Timed Up and Go (TUG)
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
The TUG evaluates mobility through the time required to rise from an arm chair, walk 3 meters, turn and walk back to the arm chair, and return to a seated position.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Change in knee range of motion (ROM)
Time Frame: Baseline, 10 weeks, 6 months, and 2 years after surgery
Assesses the mobility of the knee joint.
Baseline, 10 weeks, 6 months, and 2 years after surgery
Adherence to the intervention
Time Frame: 10 weeks after surgery
Assesses the adherence of subjects as measured by home exercise program logs and number of clinical sessions attended.
10 weeks after surgery
Satisfaction with rehabilitation program
Time Frame: 10 weeks after surgery
Assesses the satisfaction of subjects with their assigned rehabilitation program using a 5-point Likert scale ranging from "very unsatisfied" to "very satisfied".
10 weeks after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in contralateral knee whole-organ MRI scoring method (WORMS) total sum score
Time Frame: 10 weeks and 2 years after surgery
Whole-organ MRI scoring method (WORMS) is a semi-quantitative, MRI-based scoring system that evaluates the integrity of articular cartilage, ligaments/tendons, menisci, bone marrow lesions, effusion, subchondral cysts, loose bodies, and popliteal cysts. The Total sum score ranges from 0-129 and is computed by summing the following subscales: Cartilage (0-36), Ligaments/tendons (0-24), Meniscus (0-24), Bone marrow Lesions (0-18), Joint Effusion (0-3), Subchondral Cysts (0-18), Loose Bodies (0-3), and Popliteal Cyst (0-3). Higher scores indicate greater amounts of joint degeneration.
10 weeks and 2 years after surgery
Incidence of contralateral TKA
Time Frame: 2 years after surgery
Number of participants who have a contralateral TKA
2 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer E Stevens-Lapsley, PT, PhD, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 19, 2018

Primary Completion (Actual)

December 5, 2024

Study Completion (Actual)

December 5, 2024

Study Registration Dates

First Submitted

October 18, 2017

First Submitted That Met QC Criteria

October 26, 2017

First Posted (Actual)

October 30, 2017

Study Record Updates

Last Update Posted (Actual)

April 23, 2025

Last Update Submitted That Met QC Criteria

April 22, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 17-1701
  • R01AG056585 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A de-identified, anonymized dataset will be shared in a publication, which will be available through pubmed within a year of publication.

IPD Sharing Time Frame

Publications will be made available to the public through PubMed Central within one year after the date of publication.

IPD Sharing Supporting Information Type

  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Adults

Clinical Trials on Control

Subscribe